Tarsus Pharmaceuticals, Inc.
TARSNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.96B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $53.89$91.53
- Volume (live)
- -
- Avg. volume (3M)
- 908.08K
Tarsus Pharmaceuticals (TARS) Stock Price & Financial Analysis
Tarsus Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $67.65 - $71.71 |
|---|---|
| 52-Week High | $91.53 |
| 52-Week Low | $53.89 |
| Open | $71.48 |
| Volume (last close) | 556.62K |
| Average Volume (3M) | 908.08K |
| Revenue (TTM) | 606.33M |
|---|---|
| Net Income (TTM) | -46.48M |
| Free Cash Flow (TTM) | 61.55M |
| EPS (TTM) | −$1.08 |
| Profit Margin | -7.67% |
| Operating Margin | -8.00% |
| Return on Equity (ROE) | -13.40% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.96B |
|---|---|
| Shares Outstanding | 43.39M |
| Price to Sales (P/S) | 4.88 |
| Price to Book (P/B) | 8.54 |
| EV/EBITDA | -80.63 |
| 50-Day MA | $74.99 |
|---|---|
| 200-Day MA | $68.01 |
| 1-Year Change | +5.50% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Tarsus Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Tarsus Pharmaceuticals (TARS) has a market capitalization of $2.96B. The stock trades at 4.9× sales. Over the trailing twelve months it lost $46.48M on revenue of $606.33M and generated $61.55M of free cash flow. Revenue grew 105.2% year over year.
As of its latest reported balance sheet, it holds $204.59M in cash and securities against $72.76M of debt, a net cash position of $131.83M.
Tarsus Pharmaceuticals does not currently pay a dividend.
The share price is up 5.5% over the past year. At $68.20 (the Oct 23, 2026 close) it sits within its 52-week range of $53.89 to $91.53, above its 200-day moving average of $68.01.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $100.88, 47.9% above the Oct 23, 2026 close.
Frequently Asked Questions About Tarsus Pharmaceuticals
What is the current stock price for TARS?
As of the Oct 23, 2026 close, TARS stock trades at $68.20. The 52-week range is $53.89–$91.53, with a day range of $67.65–$71.71.
What is the P/E ratio for TARS?
The P/E ratio (Price-to-Earnings) for TARS is shown in the Key Statistics section. This valuation metric helps compare Tarsus Pharmaceuticals, Inc. to industry peers.
Does TARS pay dividends?
Tarsus Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TARS?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for TARS is Buy. The average 12-month price target is $100.88, a 47.9% upside from the Oct 23, 2026 close of $68.20.
What is the market cap of TARS?
As of the Oct 23, 2026 close, Tarsus Pharmaceuticals's market capitalization is $2.96B, classifying it as a mid-cap company. Tarsus Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.